ANNE GRIEPSMA: Open Payments
NPI 1316323991 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$298 in 17 payments from 10 companies in 2025. Trend: 2023 $382 · 2024 $190 · 2025 $298
Food & beverage: $298
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 5 | $86 |
| MILLICENT US INC | 2 | $37 |
| Sage Therapeutics, LLC | 2 | $35 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Evofem Biosciences, Inc. | 2 | $19 |
| Lilly USA, LLC | 1 | $19 |
| Astellas Pharma US Inc | 1 | $17 |
| SHIELD THERAPEUTICS INC | 1 | $16 |
Products named: ZURZUVAE, Exparel, Lynkuet, MYFEMBREE, INTRAROSA, Phexxi, ZEPBOUND, FEMLYV.
Industry payments across LA — which companies pay providers there.
